Financial News
All news about Sanofi-Aventis S.A.
A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
January 06, 2021
From Benzinga
3 Recession-Proof Healthcare Stocks to Buy for 2021
January 05, 2021
From Motley Fool
Market Briefing For Tuesday, Jan. 5
January 05, 2021
From Blogs - TalkMarkets
The Worst Mistake Novavax Investors Can Make Right Now
January 04, 2021
From Motley Fool
3 Top Biotech Buyout Candidates in 2021
January 04, 2021
From Motley Fool
5 Big ETF Stories Of 2020 Worth Watching In 2021
January 03, 2021
From Blogs - TalkMarkets
Week In Review: How Trump's Policies Moved Stocks -Saturday, Dec. 26
December 26, 2020
From Blogs - TalkMarkets
Here's What Investors Need to Know About Sanofi and GlaxoSmithKline's COVID Vaccine Setback
December 22, 2020
From Motley Fool
Better Coronavirus Stock: Pfizer vs. BioNTech
December 19, 2020
From Motley Fool
Where Will Novavax Be in 1 Year?
December 19, 2020
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
From Motley Fool
2 Reasons It's Not Too Late to Buy BioNTech
December 17, 2020
From Motley Fool
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
December 16, 2020
From Motley Fool
Dr. Fauci says Biden and Harris should receive COVID-19 vaccination ‘as soon as we possibly can’
December 15, 2020
From MarketWatch
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
December 15, 2020
From Motley Fool
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
December 14, 2020
From Motley Fool
‘Flight to safety’: COVID-19 has made Americans rethink the kinds of places they want to work
December 14, 2020
From MarketWatch
European stocks and U.S. equity futures rise on COVID-19 vaccine optimism and hopes for a Washington stimulus deal
December 14, 2020
From MarketWatch
Powerhouse Duo GSK, Sanofi Delay Covid Vaccine And Shares Tumble
December 11, 2020
Sanofi and GlaxoSmithKline Delay COVID-19 Vaccine Program Due to Poor Immune Response in Older Adults
December 11, 2020
From Motley Fool
U.S. suffers worst week for cases, deaths and hospitalizations since start of the pandemic
December 11, 2020
From MarketWatch
From MarketWatch
Sanofi, GSK Delay COVID Vaccine On Low Response In Older Adults
December 11, 2020
From Blogs - TalkMarkets
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
Dow poised to skid 200 point amid setbacks on U.S. fiscal relief package and Brexit
December 11, 2020
From MarketWatch
A Look Into Sanofi's Debt
December 11, 2020
From Benzinga
There’s one reason big growth stocks have outperformed over the last decade — and that’s about to change, strategist says
December 11, 2020
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.